Institut Cancerologie De L'ouest
Clinical trials sponsored by Institut Cancerologie De L'ouest, explained in plain language.
-
Radiation blitz aims to tame untreatable prostate cancer spread
Disease control Not yet recruitingThis study is for men with advanced prostate cancer that has spread to bones or lymph nodes and has stopped responding to standard treatments. Researchers want to find the maximum safe amount of tumor volume that can be treated with a precise, high-dose radiation technique. The g…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Radioactive bladder treatment trial seeks to spare patients from surgery
Disease control Not yet recruitingThis early-stage trial is testing the safety of a new radioactive drug called ATO-101 for people with a specific type of bladder cancer that has come back after standard treatments. The drug is delivered directly into the bladder to try to destroy cancer cells while aiming to spa…
Phase: PHASE1 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Could a pee test replace invasive cancer monitoring?
Knowledge-focused Not yet recruitingThis study is testing whether a simple urine test can help doctors monitor prostate or bladder cancer without invasive procedures. Researchers will collect urine samples from 25 patients at different points during their standard cancer treatment to see if they can reliably detect…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC